Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-05-10-Speech-2-424-000"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20110510.60.2-424-000"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spoken text |
"The report on the 2009 discharge for the European Medicines Agency provided for postponement of the discharge. I voted in favour of this report for three main reasons. Firstly, the European Court of Auditors found serious irregularities in several procurement procedures, including in one IT contract worth around EUR 30 million. Because of these errors, best value for money was not ensured. Secondly, the European Medicines Agency breached personnel selection rules, and thirdly it failed to prevent conflicts of interest: a month after retiring from the Agency, the former Executive Director joined a consultancy which, inter alia, advises pharmaceutical companies on developing new medicinal products and reducing the time period to their market introduction. Although the European Medicines Agency Management Board eventually decided to set limits with regard to the former Executive Director’s new and future professional activities, the discharge authority needs further explanations from the Agency on how cases of conflict of interest are actually handled."@en1
|
lpv:spokenAs | |
lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples